Parnax Lab Balance Sheet Health
Financial Health criteria checks 2/6
Parnax Lab has a total shareholder equity of ₹716.9M and total debt of ₹806.4M, which brings its debt-to-equity ratio to 112.5%. Its total assets and total liabilities are ₹1.9B and ₹1.2B respectively. Parnax Lab's EBIT is ₹184.7M making its interest coverage ratio 3.2. It has cash and short-term investments of ₹18.8M.
Key information
112.5%
Debt to equity ratio
₹806.39m
Debt
| Interest coverage ratio | 3.2x |
| Cash | ₹18.77m |
| Equity | ₹716.95m |
| Total liabilities | ₹1.17b |
| Total assets | ₹1.89b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 506128's short term assets (₹754.3M) do not cover its short term liabilities (₹818.3M).
Long Term Liabilities: 506128's short term assets (₹754.3M) exceed its long term liabilities (₹352.4M).
Debt to Equity History and Analysis
Debt Level: 506128's net debt to equity ratio (109.9%) is considered high.
Reducing Debt: 506128's debt to equity ratio has increased from 104.1% to 112.5% over the past 5 years.
Debt Coverage: 506128's debt is not well covered by operating cash flow (19.7%).
Interest Coverage: 506128's interest payments on its debt are well covered by EBIT (3.2x coverage).